Skip to main content

Chanakya

Login

Prasol Chemicals IPO

Prasol Chemicals IPO Review 2026

Prasol Chemicals IPO is a Rs. 500 crore mainboard issue comprising a fresh issue of Rs. 80 crore and an offer for sale of Rs. 420 crore. The company offers a diversified specialty-chemical portfolio, serves over 1,600 customers and exports to 69 countries. Strong FY26 growth and low leverage support the investment case, but the large OFS and full valuation require a selective approach.

IPO Snapshot

Particulars Details
Chanakya View 🟡 Selective Apply
Overall Rating ⭐⭐⭐⭐☆ (4/5)
GMP Today Rs.14 – frequently Updated
Issue Size Rs. 500 Crore
Fresh Issue Rs. 80 Crore
Offer for Sale Rs. 420 Crore
Price Band Rs. 643–Rs. 676
Lot Size 22 Shares
Minimum Retail Investment Rs. 14,872
IPO Opens 8 September 2026
IPO Closes 10 September 2026
Allotment 11 September 2026
Listing 16 September 2026
Exchange BSE and NSE
Lead Manager DAM Capital Advisors Ltd.
Registrar KFin Technologies Ltd.

Investor Decision Box

Question Chanakya View
Suitable for Listing Gain? 🟡 Yes, if GMP remains healthy
Suitable for Long-Term? 🟡 Selective
Risk Level Medium to High
Business Quality ⭐⭐⭐⭐☆
Financial Strength ⭐⭐⭐⭐⭐
Balance Sheet ⭐⭐⭐⭐☆
Valuation Comfort ⭐⭐⭐☆☆

Chanakya View

Prasol Chemicals operates a diversified specialty-chemicals business with more than 150 products used across performance chemicals, paints, inks, construction, adhesives, pharmaceuticals, agrochemicals and personal-care industries. Its broad product portfolio reduces dependence on any single chemical or end-user segment.

The company reported strong FY26 performance, with total income rising 22% to Rs. 1,237.85 crore and profit after tax increasing 91% to Rs. 83.12 crore. EBITDA improved to Rs. 139.32 crore, while ROCE of 22.43% and debt-to-equity of 0.19 reflect healthy operating efficiency and manageable leverage.

At the upper price of Rs. 676, the IPO is valued at approximately 47 times FY26 EPS of Rs. 14.33. This is broadly comparable with some recently listed specialty-chemical businesses but does not leave a large margin of safety.

The biggest concern is that Rs. 420 crore, or 84% of the issue, is an OFS. Only Rs. 80 crore represents fresh capital, primarily intended for debt repayment and general corporate purposes.

Chanakya Recommendation: 🟡 Selective Apply

About Prasol Chemicals

Incorporated in 1992, Prasol Chemicals manufactures acetone-based, phosphorus-based and other specialty chemicals. Its portfolio includes 21 acetone-based chemicals, 53 phosphorus-based chemicals and 76 other specialty products such as surfactants, esters and acids.

The company operates two manufacturing facilities at Khopoli and Mahad in Maharashtra, with an aggregate annual capacity of 98,644 metric tonnes.

As of July 31, 2026, Prasol served more than 1,600 customers and exported to 69 countries across Asia-Pacific, Europe and the Americas. Its customers include Alembic Pharmaceuticals, Lubrizol India, Rossari Biotech, Clean Science, Gharda Chemicals, Croda India and Supriya Lifescience. It is also recognised as a Three Star Export House.

Why This IPO Stands Out

✅ Diversified portfolio of more than 150 specialty chemicals.

✅ Customer base spanning five major application industries.

✅ Exports to 69 countries and established global distribution.

✅ FY26 revenue increased 22% and PAT rose 91%.

✅ Strong ROE of 20.37% and ROCE of 22.43%.

✅ Comfortable debt-to-equity ratio of 0.19.

Key Risks

⚠ The OFS constitutes 84% of the total IPO size.

⚠ Valuation at approximately 47 times FY26 earnings is not inexpensive.

⚠ Specialty-chemical demand remains exposed to economic and industry cycles.

⚠ Raw-material prices, environmental compliance and currency fluctuations may affect profitability.

⚠ FY26 figures are stated to be standalone, which may limit direct year-on-year comparability with consolidated figures.

Financial Snapshot – Rs. Crore

Particulars FY26 FY25 FY24
Total Income 1,237.85 1,015.54 887.56
EBITDA 139.32 87.77 60.53
PAT 83.12 43.57 18.13
Net Worth 448.51 367.46 325.84
Borrowings 110.06 101.05 82.07

Chanakya Interpretation: Prasol Chemicals has delivered strong revenue, margin and profit growth while maintaining comfortable leverage. Sustaining this performance after listing will be essential to justify its valuation.

Business Quality Score

Parameter Rating
Business Model ⭐⭐⭐⭐☆
Industry Outlook ⭐⭐⭐⭐☆
Financial Performance ⭐⭐⭐⭐⭐
Balance Sheet ⭐⭐⭐⭐☆
Growth Potential ⭐⭐⭐⭐☆
Valuation ⭐⭐⭐☆☆

IPO Proceeds and Why They Matter

PurposeAmount
Repayment or prepayment of borrowingsRs. 60 Crore
General corporate purposesBalance amount

Chanakya Interpretation: Debt repayment should reduce finance costs, strengthen cash flows and improve Prasol Chemicals’ balance sheet. However, the fresh issue is only Rs. 80 crore, while the Rs. 420 crore offer for sale will go to selling shareholders and provide no direct benefit to the company.

Business Outlook

India’s specialty-chemicals sector may benefit from import substitution, diversified global sourcing and rising demand from pharmaceuticals, agrochemicals, paints, construction, personal care and performance chemicals.

Prasol Chemicals has over 150 products, two manufacturing facilities with annual capacity of 98,644 MT and exports to 69 countries. Its diversified product and customer base reduces dependence on any single application industry.

Future growth will depend on capacity utilisation, new product development, export demand and margin stability. Raw-material volatility, environmental regulations and global economic weakness remain important risks.

Strengths vs Concerns

👍 Strengths⚠ Concerns
More than 150 specialty chemicalsOFS forms 84% of the issue
Over 1,600 customersValuation near 47 times FY26 EPS
Exports to 69 countriesChemical-industry cyclicality
FY26 PAT increased 91%Raw-material price volatility
Low debt-to-equity ratioEnvironmental compliance risks

Who Should Apply?

Investor TypeSuitability
Listing Gain Investors⭐⭐⭐⭐☆
Long-Term Investors⭐⭐⭐☆☆
Conservative Investors⭐⭐☆☆☆
High-Risk Investors⭐⭐⭐⭐☆

Chanakya View: Listing-gain investors may consider applying if Prasol Chemicals IPO GMP and institutional subscription remain healthy. Long-term investors should take a selective approach because strong financial growth is balanced by a full valuation and large OFS.

Chanakya Final Verdict

Prasol Chemicals offers a diversified specialty-chemicals portfolio, established export presence, reputed customers and strong FY26 financial performance. Its ROE of 20.37%, ROCE of 22.43% and debt-to-equity ratio of 0.19 indicate healthy financial quality.

However, the IPO is priced at approximately 47 times FY26 earnings, while 84% of the issue is an OFS. The investment case therefore depends on sustained earnings growth after listing.

Chanakya Recommendation: 🟡 Selective Apply

Apply for listing gains only if GMP and subscription demand remain supportive. Long-term investors may consider limited exposure and reassess the company after subsequent financial results.

Frequently Asked Questions

What does Prasol Chemicals Limited do?
It manufactures over 150 specialty chemicals used across five major industries.

What is the Prasol Chemicals IPO price band?
The price band is Rs. 643–Rs. 676 per share.

What is the Prasol Chemicals IPO minimum investment?
One retail lot of 22 shares requires Rs. 14,872.

When will Prasol Chemicals IPO list?
The tentative BSE and NSE listing date is September 16, 2026.

Should investors apply for Prasol Chemicals IPO?
Chanakya recommends Selective Apply, subject to GMP and subscription trends.

Leave a Reply

Your email address will not be published. Required fields are marked *